BUSINESS PAY AWARDS

Early day motion 1275, tabled 21 May 2003 by David Crausby (Labour). Signed by 45 members.

That this House congratulates the shareholders of GlaxoSmithKline in voting to oppose the group's controversial pay policy for senior executives; condemns individual pay packages reported as high as ú33 million regardless of performance, success or failure; notes that this is the first time United Kingdom investors have rejected such measures; and calls upon company directors to consult and involve shareholders in such important decisions especially those involving high levels of director's pay and remuneration.

Signatures by party: Labour 30, Liberal Democrat 7, Labour/Co-operative 4, Plaid Cymru 2, DUP 1, UUP 1.